Gilead Sciences CEO Daniel Patrick O'Day sold 10,000 shares of GILD stock for $1,291,600 on April 28th. This transaction reduced his overall holdings in the pharmaceutical company.
Gilead Sciences CEO Sells Over $1.29 Million in Company Stock
InsiderTradingPharmaceuticalsCEOStockSale

